Complaints from the healthcare industry that the FDA is too slow in approving new drugs and devices are not rare. Now it appears that venture capitalists are putting their money towards streamlining how the FDA approves medical devices, reports the New York Times. Minnesota representative Erik Paulsen is currently sponsoring a bill to smooth the FDA’s approval process of devices, making the process less uncertain. He argues that the current system is stifling investment that will cost states 400,000 jobs.
